Edgewood Management’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-6,250
| Closed | -$83.6K | – | 79 |
|
|
2024
Q2 | $83.6K | Hold |
6,250
| – | – | ﹤0.01% | 80 |
|
|
2024
Q1 | $290K | Hold |
6,250
| – | – | ﹤0.01% | 73 |
|
|
2023
Q4 | $423K | Hold |
6,250
| – | – | ﹤0.01% | 67 |
|
|
2023
Q3 | $453K | Hold |
6,250
| – | – | ﹤0.01% | 66 |
|
|
2023
Q2 | $465K | Hold |
6,250
| – | – | ﹤0.01% | 68 |
|
|
2023
Q1 | $333K | Buy |
6,250
+1,250
| +25% | +$66.5K | ﹤0.01% | 71 |
|
|
2022
Q4 | $338K | Buy |
5,000
+1,250
| +33% | +$84.5K | ﹤0.01% | 72 |
|
|
2022
Q3 | $468K | Buy |
3,750
+1,250
| +50% | +$156K | ﹤0.01% | 66 |
|
|
2022
Q2 | $238K | Buy |
+2,500
| New | +$238K | ﹤0.01% | 73 |
|
|
2022
Q1 | – | Sell |
-250
| Closed | -$83K | – | 85 |
|
|
2021
Q4 | $83K | Hold |
250
| – | – | ﹤0.01% | 84 |
|
|
2021
Q3 | $116K | Buy |
+250
| New | +$116K | ﹤0.01% | 82 |
|